XBiotech Share Price

XBiotech Share Price

NASDAQ: XBIT | Micro Cap | Healthcare
$1.74
-$0.05 (-2.79%) Last updated on 19 Nov, 2026 | 01:15 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

XBiotech Stock Performance

Open
$1.73
Prev. Close
$1.79
Circuit Range
N/A
Day Range
$1.73 - $1.78
Year Range
$1.73 - $2.69
Volume
570
Average Traded
$1.75

XBiotech Share Price Today

As of 19 November 2026, XBiotech Inc.'s share price is $1.74. The stock opened at $1.73, compared to its previous close of $1.79. During today's trading session, XBiotech Inc.'s share price traded between $1.73 and $1.78, with an average price of $1.75. Over the past 52 weeks, the stock has recorded a high of $2.69 and a low of $1.73. In terms of performance, XBiotech Inc.'s share price has declined by 28.69% over the last six months and is down 23.01% on a year-on-year basis.

XBiotech Share Price Chart

Line chart of the XBiotech price trend over the selected period. The price fell overall, ranging from 1.73 to 1.78, ending at 1.74.
$1.73$1.78
L
Show Current Price
H

XBiotech Stock Fundamentals & Key Indicators

Market Cap
$53.05M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.43
Revenue (TTM)
$0.00
Return On Equity (TTM)
-35.13%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
83.41%

XBiotech Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$26.89-$5.51-$6.73-$4.46
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A79.51%-22.14%33.73%

XBiotech Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$4.01$0.00$0.00$0.00
Net Profit-$32.90-$24.56-$38.53-$45.54
Net Profit Margin-820.45%N/AN/AN/A
Income ChangeN/A25.35%-56.88%-18.19%

XBiotech Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets23.1324.5324.926.26
Current Assets126.95174.57201.72219.84
Total Assets150.08199.09226.62246.1
Non Current Liabilities1.81.721.671.64
Current Liabilities7.9315.116.14.07
Total Liabilities9.7316.837.775.7
Shareholders' Equity140.35182.27218.85240.4

XBiotech Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-39.92-30.96-18.73-14.82
Investing-0.29-1.361.5-63.89
Financing-10.2510.45-0.010.0

Corporate Actions

Dividend
Ex-date: 15 Jul 2021

About XBiotech

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

XBiotech Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.91
$1.78
-8.25%
Oct 2026
$2.19
$1.94
-12.02%
Sep 2026
$2.29
$2.21
-4.34%
Aug 2026
$2.25
$2.31
+2.44%
Jul 2026
$2.31
$2.25
-2.60%
Jun 2026
$2.43
$2.31
-5.33%
May 2026
$2.56
$2.44
-3.94%
Apr 2026
$2.31
$2.54
+8.09%
Mar 2026
$2.33
$2.35
+3.07%
Feb 2026
$2.60
$2.28
-9.16%
Jan 2026
$2.34
$2.51
+6.81%
Dec 2025
$2.37
$2.35
+3.98%

XBiotech Share Price FAQs